GlycoChIP-Seq Service: Genome-Wide N-Glycosylation-Associated Chromatin Profiling
Where are high-mannose N-glycosylation-associated chromatin signals located across the genome, and how do they change with your biological condition? CD Genomics' GlycoChIP-Seq service combines ConA-biotin recognition, streptavidin enrichment, high-throughput sequencing, and control-aware analysis to map enriched chromatin regions and place them in a broader epigenomic context.
Key Project Advantages:
- Defined Molecular Scope: Profile chromatin associated with ConA-recognized, high-mannose N-glycan structures without presenting the assay as universal N- and O-glycosylation mapping.
- Background-Aware Enrichment: Use matched buffer controls and biological replicates to distinguish ConA-associated signal from nonspecific recovery.
- Chromatin-Context Integration: Compare GlycoChIP-Seq signals with H3K9me3, LADs, LINE-1 elements, accessible chromatin, transcription, or 3D genome features.
- End-to-End Support: Move from sample and control design through wet-lab enrichment, sequencing, peak analysis, visualization, and custom interpretation.
What Is GlycoChIP-Seq and What Does It Measure?
GlycoChIP-Seq is an emerging chromatin-profiling method designed to map genomic regions associated with lectin-recognized N-glycosylated chromatin complexes. In the current implementation, formaldehyde-crosslinked chromatin is fragmented and incubated with biotinylated concanavalin A (ConA). ConA recognizes mannose- and glucose-containing glycan structures, including high-mannose N-glycans. Streptavidin capture enriches the labeled chromatin complexes; associated DNA is then purified, sequenced, and analyzed across the genome.
Quick answer: GlycoChIP-Seq answers "where is ConA-recognized N-glycosylation-associated chromatin enriched?" It does not identify every glycoprotein, define a glycan structure, or assign a glycosite by sequencing alone.
The assay shifts the research question from protein-level composition to genomic location. Glycoproteomics can identify glycoproteins, glycopeptides, and site-specific glycoforms, while antibody-based ChIP-Seq maps one defined protein or histone mark. GlycoChIP-Seq instead uses a lectin-capture strategy to create a genome-wide enrichment map for a specified glycan class. These approaches are complementary, not interchangeable.
Why the Analyte Definition Matters
- Feature: ConA provides affinity for mannose/glucose-containing glycans rather than an antibody against one protein.
- Benefit: The experiment can survey a class of N-glycosylation-associated chromatin complexes without selecting one protein target in advance.
- Application: The resulting map can reveal candidate genomic regions for follow-up with glycoproteomics, ChIP-seq, CUT&RUN, perturbation, or targeted validation.
Because lectin binding is structure-dependent, the final report retains the ConA/high-mannose scope. A peak is reported as an enriched region associated with ConA-captured chromatin; it is not automatically labeled as the direct binding site of one particular N-glycosylated protein.
End-to-End GlycoChIP-Seq Workflow and QC Logic
The workflow begins with the research contrast and control design. Perturbation groups, biological replicates, background controls, reference genome, and complementary datasets are reviewed before sample processing so the final analysis can distinguish biological change from capture background.
- Study Design and Sample Review: Confirm the biological question, sample type, treatment groups, biological replicates, reference genome, and desired integrations. A matched ConA-capture and buffer-control design is planned for the approved project.
- Crosslinking and Chromatin Preservation: Cells or tissues are fixed with formaldehyde to preserve spatial associations between glycosylated proteins and chromatin. Consistent fixation across groups reduces avoidable differences in fragmentation and recovery.
- Lysis and Chromatin Fragmentation: Nuclei are extracted and chromatin is sonicated to an appropriate fragment range. Fragmentation QC helps identify under- or over-shearing before enrichment and library construction.
- ConA-Biotin Recognition: Fragmented chromatin is incubated with ConA-biotin so ConA-recognized N-glycan-associated complexes receive a biotin capture handle. A buffer control provides a reference for nonspecific background.
- Streptavidin Enrichment and DNA Recovery: Streptavidin magnetic beads capture the biotin-labeled complexes. After washing, enriched chromatin is eluted, crosslinks are reversed, and DNA is purified.
- Library Preparation, Sequencing, and Analysis: Recovered DNA is converted into sequencing libraries. Library QC, sequencing, alignment, background-aware signal generation, peak analysis, annotation, and comparative interpretation produce the final result package.
QC Checkpoints Reported with the Project
- Sample identity, cell viability or tissue condition, crosslinking status, and group/replicate structure.
- Chromatin fragmentation review and recovered-DNA assessment.
- Library concentration and fragment-size distribution.
- Read-quality summary, clean-read yield, mapping statistics, duplicate review, and usable-read statistics.
- Replicate similarity, control behavior, signal enrichment, and peak or domain reproducibility appropriate to the approved design.
Acceptance criteria are finalized for the project rather than presented as a universal threshold for every species, matrix, and biological question.
Review Your Sample and Control PlanSample Requirements and Handling
The following parameters come from the current supplier workflow and are used for initial planning. Final acceptance depends on tissue composition, species, experimental groups, fixation history, and the number of control arms.
| Sample Type | Planning Input | Preparation and Quality | Handling Notes |
|---|---|---|---|
| Cultured Cells | 1 × 10^8 cells | Viability greater than 90% before fixation | Fix to a final concentration of 1% formaldehyde; store the crosslinked cell pellet at −80°C |
| Animal Tissue | More than 500 mg | Freshly collected material suitable for uniform crosslinking | Heart, liver, spleen, lung, kidney, and other matrices require project review; ship crosslinked material on dry ice |
| Plant Tissue | More than 5 g | Tissue should be collected and fixed consistently across groups | Leaves and other matrices require species- and tissue-specific feasibility review; ship on dry ice |
| Other Sample Formats | Project-specific | Feasibility, biomass, fixation, and reference-genome quality are reviewed before collection | Do not assume direct transfer from the current cell/tissue workflow |
Do not add TRIzol or another lysis reagent before submission. Crosslinking, storage, and shipment instructions should be confirmed before collection, particularly for unusual tissues, plants, limited specimens, or non-model organisms.
Bioinformatics from Raw Reads to Chromatin Context
GlycoChIP-Seq analysis is designed to preserve the difference between the measured enrichment signal and the biological hypothesis built from it. Standard processing produces an auditable genome-wide map; comparative and multi-omics layers then test whether that map changes with the experimental variable or overlaps relevant chromatin features.
Core Processing and Enrichment Analysis:
- Raw Data QC and Trimming: Review base quality, adapter content, read yield, and sequence composition before removing adapters and low-quality reads.
- Alignment and Filtering: Map clean reads to the approved reference genome, remove low-confidence or problematic alignments according to the analysis plan, and summarize usable reads.
- Control-Aware Signal Tracks: Generate normalized genome-browser tracks and ConA-versus-buffer signal views so enrichment can be inspected rather than inferred from peaks alone.
- Peak or Enriched-Region Detection: Identify statistically supported enrichment regions with parameters suited to the observed signal shape, then retain the control and replicate context for review.
- Genomic Annotation: Assign enriched regions to promoters, exons, introns, distal intergenic regions, repeat classes, chromosomes, and nearby genes as appropriate.
- Differential Enrichment: Compare consensus regions across treatment, genotype, mutation, developmental, metabolic, or other matched biological groups.
Functional and Integrative Analysis:
- GO and pathway enrichment for genes associated with differential regions.
- Venn or overlap analysis for shared and condition-specific regions.
- Chromosome distribution, region-length distribution, heatmaps, clustering, and volcano-style differential summaries.
- Motif analysis as a hypothesis-generating sequence-context layer, not proof that the motif-binding factor is present.
- Overlap and enrichment analysis with H3K9me3, LADs, LINE-1 or other repeat annotations.
- Integration with ATAC-Seq, RNA-seq, Hi-C, ChIP-seq, or CUT&RUN to connect the GlycoChIP-Seq landscape with accessibility, expression, chromatin marks, and genome organization.
Projects that already have sequencing data can extend the standard pipeline through custom epigenomic data analysis.
Results and Deliverables
The deliverable package is organized so the wet-lab design, raw data, QC evidence, region tables, and interpretation can be traced together.
Standard Deliverables:
- Project design and sample/control summary.
- Raw sequencing data and clean-read files.
- Sequencing and alignment QC report.
- Normalized genome-browser signal tracks.
- Enriched-region/peak tables and genomic annotations.
- Differential enriched-region tables for approved comparisons.
- Genomic-feature, chromosome, length, overlap, heatmap, cluster, and differential visualizations.
- GO/pathway and motif results when included in the approved analysis plan.
- Multi-omics overlap or integration outputs when complementary data are supplied or co-generated.
- Final report with method notes, result interpretation, and project-specific limitations.
Representative Result Views:
- Control-Aware Genome Tracks: ConA and buffer-normalized signals show where enrichment occurs and whether the pattern changes across conditions.
- Peak Annotation and Distribution: Region tables and feature summaries describe where signals fall in the genome without assigning an unsupported molecular identity.
- Differential Signal Panel: Replicate-aware heatmaps, clustering, and volcano-style plots prioritize regions that change with the biological contrast.
- Chromatin-Context Matrix: Overlap with H3K9me3, LADs, repeats, accessibility, transcription, or 3D genome features organizes follow-up hypotheses.
Illustrative result formats only. The planned artwork contains no project-derived values, universal QC thresholds, or fabricated performance data.
Applications in Glycobiology and Epigenetics Research
GlycoChIP-Seq is most informative when the project asks how a defined perturbation changes the genomic distribution of ConA-recognized N-glycosylation-associated chromatin and then tests that pattern against another biological layer.
Map whether N-glycosylation-associated chromatin is enriched near H3K9me3 domains, repetitive elements, or other repressive regions, then compare the pattern after glycosylation-pathway inhibition, protein mutation, or chromatin perturbation. Pairing with H3K9me3 ChIP-seq or CUT&RUN helps separate a glycan-associated enrichment change from a broader shift in heterochromatin.
Study how N-glycosylated inner-nuclear-membrane proteins may relate to lamina-associated domains and nuclear-periphery chromatin. GlycoChIP-Seq provides the genomic enrichment layer, while Hi-C, spatial annotations, imaging, or protein-level validation addresses architecture and molecular identity.
Compare cells or tissues across glucose conditions, enzyme inhibition, pathway perturbation, knockout, or rescue designs to test whether nuclear N-glycosylation-associated chromatin responds to metabolic state. RNA-seq and chromatin-mark profiling can show whether enrichment changes coincide with altered transcription or epigenetic state.
Track N-glycosylation-associated chromatin during lineage transitions, differentiation, reprogramming, or developmental perturbations. The method is best used as one layer in a matched design that also measures expression, chromatin accessibility, or lineage-relevant histone marks.
Evaluate enrichment near LINE-1 or other annotated repeat classes and determine whether it changes after perturbing glycosylation or heterochromatin regulators. Repeat-aware alignment and interpretation are important because signal mappability and genomic copy number can influence apparent enrichment.
Use hypothesis-driven models to ask whether disease-associated mutation, therapy exposure, metabolic stress, senescence, or aging-related perturbation alters the enrichment landscape. These are emerging research applications and require orthogonal functional evidence rather than stand-alone biomarker interpretation.
Combine GlycoChIP-Seq with accessibility, transcription, histone marks, 3D genome, and glycoproteomics data. Coordinated profiling can move a project from "where is the signal?" to a prioritized model connecting glycan-associated chromatin, chromatin state, gene regulation, and candidate proteins.
Explore conserved or species-specific N-glycosylation-associated chromatin patterns in suitable animal or plant systems when sample preparation and reference-genome quality support the design. New matrices should pass feasibility review before collection because the direct evidence base remains concentrated in mouse cell models.
Foundational Evidence and Current Method Scope
The foundational 2026 study by Tang and colleagues used ConA-based chromatin profiling in mouse embryonic stem cells and reported N-glycosylation-associated enrichment in H3K9me3-marked heterochromatin, LINE-1 regions, and lamina-associated domains. The study also combined GlycoChIP-Seq with H3K9me3 ChIP-seq, CUT&RUN, perturbation, and 3D genome analyses to examine the relationship between nuclear N-glycosylation, TMPO, SETDB1, and genome stability.
The associated NCBI GEO record, GSE273948, is publicly available and includes ConA-ChIP-seq and buffer-control replicates together with companion chromatin datasets. This public record confirms that the method has moved beyond a conceptual proposal and provides a transparent reference for experimental and analytical design.
At the same time, the evidence base is still narrow. Results from mouse embryonic stem cells and mouse embryonic fibroblasts should not be generalized automatically to every tissue, species, or disease model. CD Genomics therefore treats new matrices as feasibility-reviewed research projects and recommends matched controls, biological replication, and orthogonal validation.
Original conceptual illustration based on the verified evidence scope of Tang et al. (2026) and GEO GSE273948; no source figure or published data graphic is reproduced.
Choose GlycoChIP-Seq, ChIP-Seq, or Glycoproteomics
| Method | Primary Question | Capture Principle | Main Readout | Best For | Not For |
|---|---|---|---|---|---|
| GlycoChIP-Seq | Where is ConA-recognized N-glycosylation-associated chromatin enriched? | ConA-biotin plus streptavidin enrichment | Genome-wide enriched regions and signal tracks | Perturbation-aware mapping and chromatin-context integration | Universal glycan mapping or direct glycoprotein/glycosite identification |
| ChIP-Seq | Where does one defined protein or histone mark associate with chromatin? | Target-specific antibody immunoprecipitation | Protein- or mark-specific genomic occupancy | Defined TFs, chromatin proteins, and histone modifications | Unbiased capture of a glycan class |
| Glycoproteomics | Which proteins, glycopeptides, sites, or glycoforms are present? | Glycan/glycopeptide enrichment plus LC–MS/MS | Protein-level and site-level molecular identification | Glycoprotein identity, glycosite, and glycoform analysis | Genome-coordinate mapping of associated chromatin |
Best for: comparative projects with a defined N-glycosylation/chromatin hypothesis, sufficient crosslinked material, matched buffer controls, and biological replicates.
Not for: all-glycan discovery, O-glycosylation mapping without a validated alternative capture workflow, clinical testing, or projects that require one sequencing peak to prove a specific glycoprotein, glycosite, or causal mechanism.
For broader method selection, review the Chromatin Analysis service portfolio.
Frequently Asked Questions
References
- Tang X, et al. "Nuclear N-glycosylation maintains H3K9me3 heterochromatin and genomic stability." Nature Cell Biology. 2026;28:1269–1280.
- Bojar D, et al. "A useful guide to lectin binding: machine-learning directed annotation of 57 unique lectin specificities." ACS Chemical Biology. 2022;17:2993–3012.
- Landt SG, et al. "ChIP-seq guidelines and practices of the ENCODE and modENCODE consortia." Genome Research. 2012;22:1813–1831.
- Zhang Y, et al. "Model-based analysis of ChIP-Seq (MACS)." Genome Biology. 2008;9:R137.
- Padeken J, et al. "Establishment of H3K9-methylated heterochromatin and its functions in tissue differentiation and maintenance." Nature Reviews Molecular Cell Biology. 2022;23:623–640.
- Tang X, et al. "The PTM profiling of CTCF reveals the regulation of 3D chromatin structure by O-GlcNAcylation." Nature Communications. 2024;15:2813.
- van Steensel B, Belmont AS. "Lamina-associated domains: links with chromosome architecture, heterochromatin, and gene repression." Cell. 2017;169:780–791.
For Research Use Only. This service is not intended for diagnostic procedures, patient management, or treatment decisions. Project feasibility, sample acceptance, controls, sequencing strategy, and analysis scope are finalized according to the submitted material and research objective.